Characteristics of NSCLC Patients Treated in First Line Treatment with Tyrosine Kinase Inhibitors (TKI) - Real Data from the Czech Republic
Authors | |
---|---|
Year of publication | 2017 |
Type | Conference abstract |
MU Faculty or unit | |
Citation | |
Description | Characteristics of NSCLC Patients Treated in First Line Treatment with Tyrosine Kinase Inhibitors (TKI) - Real Data from the Czech Republic. |